Aileron Therapeutics
Why Robinhood?
You can watch ALRN and buy or sell other stocks, ETFs, and their options commission-free!About ALRN
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
ALRN Key Statistics
Stock Snapshot
With a market cap of 371.37M, Aileron Therapeutics(ALRN) trades at $4.33. The stock has a price-to-earnings ratio of -0.46.
During the trading day, Aileron Therapeutics(ALRN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 513.44K.
Over the past 52 weeks, Aileron Therapeutics(ALRN) stock has traded between a high of $2.18 and a low of $0.69.
Over the past 52 weeks, Aileron Therapeutics(ALRN) stock has traded between a high of $2.18 and a low of $0.69.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.